Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study

Journal of Acquired Immune Deficiency Syndromes

Volumn 59, Issue 1, 2012, Pages 79-85

  Staehelin, Cornelia ^a   Keiser, Olivia ^b   Calmy, Alexandra ^c   Weber, Rainer ^d   Elzi, Luigia ^e   Cavassini, Matthias ^f   Schmid, Patrick ^g   Bernasconi, Enos ^h   Furrer, Hansjakob ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^g CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^h REGIONAL HOSPITAL OF LUGANO   (Switzerland)

Author keywords

adherence; cohort study; HIV infection; migrants; sub Saharan Africa; viral failure

Indexed keywords

ANTIRETROVIRUS AGENT; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICA SOUTH OF THE SAHARA; ARTICLE; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF REPORT; SURVIVAL; SWITZERLAND; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AFRICA SOUTH OF THE SAHARA; AFRICAN CONTINENTAL ANCESTRY GROUP; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SWITZERLAND; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 83655201367     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318236be70     Document Type: Article

References (26)

1. European Centre for Disease Prevention and Control WHO Regional Office for Europe HIV/AIDS surveillance in Europe 2009. 2010.
2. Hamers FF, Downs AM. The changing face of the HIV epidemic in western Europe: what are the implications for public health policies? Lancet. 2004;364:83-94. (Pubitemid 38968629)
3. Robert Koch Institut. Robert Koch Insitut, Epidemiologisches Bulletin November 2010. 2010.
4. Health Protection Agency Centre for Infections-HIV/STI Department. 2010.
5. Bundesamt für Gesundheit. HIV-Quartalszahlen per 31. Dezember 2010. 2010.
6. Bundesamt für Statistik. Wohnbevölkerung nach detaillierter Staatsangehörigkeit Available at: http://www.bfs.admin.ch/bfs. Accessed February 17, 2011.
7. Staehelin C, Rickenbach M, Low N, et al. Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival. AIDS. 2003;17:2237-2244. (Pubitemid 37338897)
8. Staehelin C, Egloff N, Rickenbach M, et al. Migrants from sub-Saharan Africa in the Swiss HIV Cohort Study: a single center study of epidemiologic migration-specific and clinical features. AIDS Patient Care STDS. 2004;18:665-675. (Pubitemid 39579160)
9. Nellen JF, Wit FW, De Wolf F, et al. Virologic and immunologic response to highly active antiretroviral therapy in indigenous and nonindigenous HIV-1-infected patients in the Netherlands. J Acquir Immune Defic Syndr. 2004;36:943-950. (Pubitemid 38944090)
10. van den Berg JB, Hak E, Vervoort SC, et al. Increased risk of early virological failure in non-European HIV-1-infected patients in a Dutch cohort on highly active antiretroviral therapy. HIV Med. 2005;6:299-306. (Pubitemid 41335137)
11. Frater AJ, Dunn DT, Beardall AJ, et al. Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy. AIDS. 2002;16:1139-1146. (Pubitemid 34533852)
12. The Swiss HIV Cohort Study. Cohort Profile: The Swiss HIV Cohort Study. Int J Epidemiol. 2010;39:1179-1189.
13. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41(RR-17): 1-19.
14. UNAIDS. UNAIDS report on the global AIDS epidemic 2010. 2011.
15. Ledergerber B, Egger M, Opravil M, et al. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet. 1999;353:863-868. (Pubitemid 29126872)
16. Casado JL, Perez-Elias MJ, Antela A, et al. Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients. AIDS. 1998;12:F131-F135. (Pubitemid 28330716)
17. Glass TR, De Geest S, Weber R, et al. Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2006;41: 385-392.
18. Breton G, Lewden C, Spire B, et al. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France. HIV Med. 2007;8:164-170. (Pubitemid 46915687)
19. Miller V, Staszewski S, Sabin C, et al. CD4 lymphocyte count as a predictor of the duration of highly active antiretroviral therapy induced suppression of human immunodeficiency virus load. J Infect Dis. 1999; 180:530-533. (Pubitemid 30256342)
20. Lima VD, Harrigan R, Murray M, et al. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals [miscellaneous article]. AIDS. 2008;22:2371-2380.
21. European AIDS Clinical Society. European Guidelines for treatment of HIV infected adults in Europe-2009. 2009 .
22. Ballif M, Ledergerber B, Battegay M, et al. Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007. PLoS One. 2009;4:e8275. doi:10.1371/journal.pone. 0008275.
23. García de Olalla P, Knobel H, Carmona A, et al. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J Acquir Immune Defic Syndr. 2002;30:105-110. (Pubitemid 34506694)
24. Wood E, Hogg RS, Yip B, et al. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L. Ann Intern Med. 2003;139:810-816.
25. Thierfelder C, Furrer H, Elzi L. Participation and retention of immigrants in the Swiss HIV Cohort Study (SHCS) [Abstract]. Presented at: XVIII International AIDS Conference; 2010, Vienna, Austria. Abstract No TUPE0408 2010.
26. Dominice Dao MI, Ferreira JF, Vallier N, et al. Health perceptions of African HIV-infected patients and their physicians. Patient Educ Couns. 2010;80:185-190.